iBio CMO LLC is a 70 percent subsidiary of iBio jointly owned with affiliates of Eastern Capital Limited for development and large-scale manufacture of plant-made pharmaceuticals. The iBio CMO multiproduct facility includes laboratory and pilot-scale operations as well as large-scale automated hydroponic systems capable of growing over 4 million plants as "in process inventory" and delivery of over 300 kilograms of finished therapeutic protein per year. This translates into more than a half million doses per year of a typical therapeutic antibody and approximately 50 million vaccine doses every three weeks
More dilution. He always screws the shareholder. Aren't they making enough from grants?? Guess not.
Besides nothing in production to generate revenue.
If he doesn't he's a pumper.
So steve why haven't you deleted this thread since you posted incorrect information? Are you just a lying pumper??
I can find no mention of IBIO in any of those articles. It looks like the money is going to Novartis and various Universities. Please post a link that mentions IBIO. thx
You guys are thinking way too low. GSS will produce 250,000ozs next year. When gold is only $2000 GSS revenue will be $500,000,000.00. GSS pps high was $21 back in 1996. It hit $8.64 in 2003 and $6.01 in 2010. Come on folks think bigger and longer term.
One more warning needs to be heeded here. Dr. Anthony Fauci, who oversees the National Institutes of Health’s efforts on allergy and infectious diseases, as well as emerging diseases such as Ebola and Zika, has warned that no virus cure exists now nor will in the immediate future. He has said:
We will not have a widely available safe and effective Zika vaccine this year and probably not even in the next few years.
Scientist's are worried people will contract Zika in Brazil and fly home spreading the virus. Some have suggested the Olympics be moved or cancelled.